Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NOVARTIS CORPORATION et al v. TEVA PHARMACEUTICALS USA INC
Case Number:
2:04-cv-04473
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 21, 2011
Novartis, Teva End Long-Running Lotrel Patent Suit
Novartis Corp. and Teva Pharmaceuticals USA Inc. buried the hatchet Wednesday in a seven-year-old patent dispute in New Jersey over hypertension drug Lotrel, with a federal judge approving a settlement.
-
September 21, 2004
Novartis Sues Teva Over ANDA For Generic Lotrel
Swiss pharmaceutical company Novartis AG has sued Israeli generics maker Teva Pharmaceutical Industries Ltd. to block a generic version of its hypertension drug Lotrel.